Pneumolysin-damaged cells benefit from non-homogeneous toxin binding to cholesterol-rich membrane domains

Authors:

Abstract
No abstract available
Funding Information
  • Novartis Foundation for Medical-biological Research (16B100)
  • Swiss National Science Foundation (SNF 31003A_159414)
  • Gebert Rüf Foundation
  • European Research Council (681587)
  • University of Bern

This publication has 45 references indexed in Scilit: